top of page
News
Nov 26, 2019
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Aug 22, 2018
Alpha Tau’s High-Precision Cancer Radiotherapy Receives Radioactive-Safety Approval in the United St
The new Sealed Source and Device (SSD) approval enables the commencement of clinical trials in leading hospitals across the U.S. with the...
Aug 22, 2018
Israeli Medical Startups Beat a Path to Aging Japan
[..] Another company from Tel Aviv, Alpha Tau Medical, has partnered with Japanese biotechnology startup HekaBio to release radiation...
Jul 15, 2018
CEO Uzi Sofer Reveals Great News on Galatz Radio 02.07.2018
Alpha Tau Medical focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for...
bottom of page